Mrs Melinda Alexandria Mihalich, CCC SLP | |
1327 Kalakaket Street, Fairbanks, AK 99709 | |
(907) 452-4517 | |
(907) 452-4263 |
Full Name | Mrs Melinda Alexandria Mihalich |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1327 Kalakaket Street, Fairbanks, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063603611 | NPI | - | NPPES |
A021 | Other | TRICARE | |
SP4171 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 230 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Melinda Alexandria Mihalich, CCC SLP Po Box 60543, Fairbanks, AK 99706 Ph: (907) 474-9705 | Mrs Melinda Alexandria Mihalich, CCC SLP 1327 Kalakaket Street, Fairbanks, AK 99709 Ph: (907) 452-4517 |
News Archive
NovaDel Pharma Inc., today announced that it received an Issue Notification from the United States Patent and Trademark Office (USPTO) for a new U.S. Patent, No. 7632517, entitled "Buccal, Polar and Non-polar Spray Containing Zolpidem," which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaDel's oral spray technology.
Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
iBio, Inc. confirmed today the grant of rights to use iBio's proprietary technology, the iBioLaunchâ„¢ platform, in support of a $5.3 million government-funded project for the development of a single vaccine to protect against both anthrax and plague. The project will be managed by Fraunhofer USA Center for Molecular Biotechnology (CMB) pursuant to the long-term agreement between iBio and CMB for advancement of the iBio technology.
› Verified 6 days ago
Mrs. Kathleen Forehand Hall, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263 | |
Conversation Station Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 University Ave Ste 110, Fairbanks, AK 99709 Phone: 907-687-6309 | |
Ms. Heather E Eisenman, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1528 Bluegrass Dr, Fairbanks, AK 99709 Phone: 707-364-2013 | |
Kerry Rae Pippin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 1st Ave, Fairbanks, AK 99701 Phone: 907-347-6494 | |
David Jamison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket St, Fairbanks, AK 99709 Phone: 907-452-4517 | |
Mackenzee Heath, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Chapman Ct, Fairbanks, AK 99709 Phone: 907-374-1686 Fax: 866-308-4995 |